Log In
BCIQ
Print this Print this
 

NESS070C5

  Manage Alerts
Collapse Summary General Information
Company Neuroscienze PharmaNess s.c.a r.l.
Description 
Molecular Target Cannabinoid CB2 receptor (CNR2)
Mechanism of ActionCannabinoid CB2 receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic inflammatory pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today